Insider activity (SEC Form 4)
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
Open-market · last 30 days:
0 buyers bought $0
9 sellers sold $30.5M
Open-market · last 90 days:
0 buyers bought $0
10 sellers sold $32.3M
| Insider | Role | Date | Transaction | Shares | Value |
| Abd El Hak Hesham |
CEO-Baby and Feminine Care |
2026-11-12 |
Open-market sell |
2250 |
$379K |
| Santos de Azevedo Juliana Monteiro |
CEO - Grooming |
2026-11-05 |
Open-market sell |
5370 |
$908K |
| Schulten Andre |
Chief Financial Officer |
2026-11-05 |
Option exercise |
30677 |
$2.4M |
| Schulten Andre |
Chief Financial Officer |
2026-11-05 |
Open-market sell |
30677 |
$5.2M |
| Schulten Andre |
Chief Financial Officer |
2026-11-04 |
Option exercise |
33624 |
$3.1M |
| Schulten Andre |
Chief Financial Officer |
2026-11-04 |
Open-market sell |
33624 |
$5.5M |
| Janzaruk Matthew W. |
SVP - Chief Accounting Officer |
2026-11-03 |
Option exercise |
9479 |
$934K |
| Janzaruk Matthew W. |
SVP - Chief Accounting Officer |
2026-11-03 |
Open-market sell |
9479 |
$1.5M |
| Aguilar Moses Victor Javier |
Chf Rsch, Dev & Innov Officer |
2026-10-30 |
Option exercise |
18812 |
$1.5M |
| Aguilar Moses Victor Javier |
Chf Rsch, Dev & Innov Officer |
2026-10-30 |
Open-market sell |
18812 |
$3.1M |
| Gama Paul |
CEO- Health Care |
2026-10-30 |
Open-market sell |
2894 |
$478K |
| Raman Sundar G. |
CEO-Fabric Home & Habitat Care |
2026-10-30 |
Option exercise |
38253 |
$3.8M |
| Raman Sundar G. |
CEO-Fabric Home & Habitat Care |
2026-10-30 |
Open-market sell |
38253 |
$6.3M |
| Gama Paul |
CEO- Health Care |
2026-10-23 |
Open-market sell |
4331 |
$698K |
| Jejurikar Shailesh |
Chairman, President and CEO, Director |
2026-10-23 |
Option exercise |
35000 |
$2.7M |
| Jejurikar Shailesh |
Chairman, President and CEO, Director |
2026-10-23 |
Open-market sell |
35000 |
$5.7M |
| Purushothaman Balaji |
Chief Human Resources Officer |
2026-10-23 |
Open-market sell |
4181 |
$672K |
| ARNOLD CRAIG |
Director |
2026-10-13 |
Grant/award |
1438 |
$0 |
| Allen Bertrand Marc |
Director |
2026-10-13 |
Grant/award |
1438 |
$0 |
| Biggs M. Brett |
Director |
2026-10-13 |
Grant/award |
1438 |
$0 |
Most recent 20 reported transactions. Open-market buys (P) and sells (S) are the deliberate ones; grants and option exercises are compensation. Not investment advice.
Fiscal period ending 2026-06-30 versus 2025-06-30
— view filing on EDGAR →
Geopolitical, competitive, and operational risks all moved adversarially in the same direction, with no offsetting easing. The most consequential shifts are the escalation of Russia sanctions language to "significant and cumulative," the explicit addition of Middle East conflict exposure, and new cyber/third-party liability disclosures that materially expand the legal and reputational risk surface. Competitive pressure is compounding simultaneously, with buying alliances and digital-driven customer leverage newly called out as structural negotiation headwinds.
1 company-specific
· 3 common-mode
Company-specific changes
Revised
Added explicit disclosure of "buying alliances" and "changing customer practices driven by digital tools and investment in media platforms" as new negotiation pressures, escalating customer concentration risk.
A significant change in customer relationships or in customer demand for our products could have a significant impact on our business. We sell most of our products via retail customers, which include…
Also disclosed — common-mode (Geopolitical macro uncertainty, Generative AI competition disruption, AI cybersecurity escalation)
Geopolitical macro uncertainty
Revised
Added Middle East conflict as new geopolitical risk; escalated Russia language from "could" to "significant and cumulative" sanctions; broadened scope of potential conflicts.
Changing political and geopolitical conditions could adversely impact our business and financial results. Changes in the political conditions in markets in which we manufacture, sell or distribute…
Generative AI competition disruption
Revised
Escalated competitive intensity: "increasing number" of competitors added; pace of change now emphasized as critical risk factor requiring faster response.
The ability to achieve our business objectives depends on how well we can compete with our local and global competitors in new and existing markets and channels. The consumer products industry is…
AI cybersecurity escalation
Revised
Added explicit cyber incident risk and third-party liability exposure. New language on government inquiries/investigations materially expands disclosed legal and reputational risks.
We rely on third parties in many aspects of our business, which creates additional risk. Due to the scale and scope of our business, we must rely on relationships with third parties, including our…
Fiscal period ending 2025-06-30 versus 2024-06-30
— view filing on EDGAR →
Interest rate risk has been explicitly added to the financial risk profile, expanding exposure beyond the prior currency-only framing to include debt refinancing risk and rate differentials. This is a localized but meaningful escalation in disclosed financial risk, concentrated in a single theme with no offsetting easing elsewhere.
0 company-specific
· 1 common-mode
Also disclosed — common-mode (Debt leverage refinancing)
Debt leverage refinancing
Revised
Added explicit interest rate risk exposure tied to debt refinancing and rate differentials, escalating financial risk beyond prior currency-only focus.
MACROECONOMIC CONDITIONS AND RELATED FINANCIAL RISKS Our business is subject to numerous risks as a result of having significant operations and sales in international markets, including foreign…
Material year-over-year changes to this company's Risk Factors (Item 1A), found by comparing each annual report to the prior year, judged for materiality, and classified as company-specific or common-mode against the cross-company catalog. Common-mode changes are the macro themes many companies disclose in common; they are collapsed above. A filing marked unchanged had no material change from the prior year; its summary describes the company's standing risks, which remain in force. Fiscal periods are the reporting period ends. Not investment advice.
8-K
filed 2026-10-22
confidence 99%
Item 2.02
This is a straightforward earnings release for Procter & Gamble's fiscal year 2027 first quarter ended September 30, 2026. The 8-K Item 2.02 explicitly states the Company "issued a news release with respect to earnings for the quarter ended September 30, 2026," and the attached exhibit (EX-99.1) is the formal news release disclosing net sales of $23.3 billion (+4.0%), diluted EPS of $1.97 (+1%), core EPS of $2.00 (+1%), along with segment performance, guidance updates, and cash flow metrics. This is a material disclosure affecting investor assessment of the registrant's financial performance and outlook.
View raw filing on EDGAR →
8-K
filed 2026-10-22
confidence 98%
Item 7.01
The filing discloses Procter & Gamble's first quarter fiscal 2027 financial results, including organic sales growth of +4.0%, core EPS of $2.00 (+1% vs. prior year), and segment-level performance across all five business units. The press release and accompanying slides present comprehensive quarterly earnings data, forward guidance for FY 2027, and management commentary on business performance—the hallmark of an earnings release disclosure under Item 7.01 (Regulation FD Disclosure).
View raw filing on EDGAR →
8-K
filed 2026-07-29
confidence 99%
Item 2.02
P&G issued a news release on July 29, 2026 disclosing fourth quarter and fiscal year 2026 financial results, including net sales of $87.0 billion (+3% FY, +2% Q4), diluted EPS of $6.62 (+2% FY, -15% Q4), and core EPS of $6.89 (+1% FY, -3% Q4), along with segment performance details and fiscal 2027 guidance. This is a standard quarterly/annual earnings release furnished under Item 2.02.
View raw filing on EDGAR →
8-K
filed 2026-07-29
confidence 85%
Item 5.02
Shailesh Jejurikar has been appointed as Chairman of the Board effective August 1, 2026, in addition to his existing role as President and CEO, representing a significant governance change at the company.
View raw filing on EDGAR →
8-K
filed 2026-07-29
confidence 98%
Item 7.01
P&G issued a press release on July 29, 2026 announcing fourth quarter and fiscal year 2026 results, with detailed financial metrics including organic sales growth (+1%), core EPS growth (+1%), and segment performance data. The company also provided FY 2027 guidance. This is a standard earnings release disclosure furnished under Item 7.01 (Regulation FD Disclosure), with supporting slides (EX-99.1) containing comprehensive financial results and forward-looking guidance.
View raw filing on EDGAR →
8-K
filed 2026-07-14
confidence 99%
Item 7.01
The filing discloses the Board of Directors' declaration of a quarterly dividend of $1.0885 per share on Common Stock and preferred shares, payable August 17, 2026. This is a routine but material dividend declaration by a major dividend-paying company with 136 consecutive years of dividend payments and 70 consecutive years of dividend increases, reinforcing P&G's commitment to return cash to shareholders.
View raw filing on EDGAR →